Oruka Therapeutics (ORKA) Amortizatization of Intangibles (2015 - 2026)
Oruka Therapeutics (ORKA) recorded quarterly Amortizatization of Intangibles of $446000.0 in Q1 2026, down 32.73% quarter-over-quarter from $663000.0 in Q4 2025, and down 75.18% on a YoY basis from $1.8 million in Q1 2025.
Oruka Therapeutics (ORKA) Amortizatization of Intangibles (2015 - 2026) Analysis & Trends
Oruka Therapeutics' Amortizatization of Intangibles history runs 12 years deep, the most recent figure standing at $446000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 75.18% year-over-year to $446000.0; the TTM figure through Mar 2026 stood at $3.7 million (up 98.26% YoY), while the FY2025 annual figure was $5.0 million, up 122.85% from the prior year.
- Amortizatization of Intangibles was $446000.0 for Q1 2026 at Oruka Therapeutics, down from $663000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.8 million in Q1 2025 to a low of $9000.0 in Q2 2024.
- Historically, Amortizatization of Intangibles has averaged $377600.0 across 5 years, with a median of $25000.0 in 2023.
- The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles surged 16600.0% in 2025, then tumbled 75.18% in 2026.
- A 5-year view of Amortizatization of Intangibles shows it stood at $24000.0 in 2022, then retreated by 16.67% to $20000.0 in 2023, then slumped by 55.0% to $9000.0 in 2024, then surged by 7266.67% to $663000.0 in 2025, then slumped by 32.73% to $446000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $446000.0 (Q1 2026), $663000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Oruka Therapeutics | 3.54 Bn | 3.16 Bn | - | 446,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 446,000.00 |
| Mar 31, 2026 | 446,000.00 |
| Dec 31, 2025 | 663,000.00 |
| Dec 31, 2025 | 663,000.00 |
| Sep 30, 2025 | 1.04 Mn |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Jun 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Jun 30, 2023 | 25,000.00 |
| Jun 30, 2023 | 25,000.00 |